Can selective Bb inhibition give NovelMed Therapeutics an edge in the multibillion-dollar PNH drug market?
What the Mount Raymond acquisition means for SLAM Exploration Ltd.’s Goodwin project scale (TSXV: SXL)
Read More 6 minute read General business news Could Switzerland lose UBS? Bank weighs U.S. move amid strict new capital mandate UBS is reportedly weighing a move to the U.S. amid a Swiss capital rules row that could cost it $26B. Find out what’s driving this high-stakes shift. byPallavi MadhirajuSeptember 15, 2025